ArticleNeoplasia (New York, N.Y.)2008

Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.

Lisa D Volk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.